Weekly recap

Wall Street analyst calls: Mar 30 – Apr 5, 2026

28 research notes from 19 Wall Street firms on 15 companies. 2 upgrades, 0 downgrades, 2 initiations, 3 price-target increases and 8 cuts.

Upgrades 2

New coverage 2

Biggest price-target increases 3

Biggest price-target cuts 8

Most-covered companies

Most active firms

All notes 28

  1. JPMorgan Raises TSMC Price Target to NT$2,400
  2. Goldman Sachs Lowers Rivian’s Price Target to $17
  3. DA Davidson Reiterates Neutral Rating on Intel
  4. Wells Fargo Lowers Alphabet Price Target to $361
  5. Wells Fargo Lowers Meta Price Target to $765
  6. DA Davidson Reiterates Neutral on Intel, $45 Price Target
  7. Wedbush Reiterates Outperform on Tesla, $600 Price Target
  8. Freedom Broker Lowers Tesla Price Target to $400
  9. Truist Securities Lowers Tesla Price Target to $400
  10. Cantor Fitzgerald Reiterates Overweight Rating on Micron
  11. RBC Capital Reiterates Outperform Rating on Marvell
  12. Wells Fargo Raises Arm Holdings Price Target to $175
  13. Benchmark Reiterates Buy on NVIDIA, $250 Price Target
  14. DA Davidson Upgrades Rivian to Neutral
  15. Benchmark Initiates Coverage on Palantir at Hold
  16. Citi Lowers Micron Price Target to $425
  17. BofA Securities Raises Marvell Price Target to $125
  18. Rosenblatt Positive on NVIDIA-Marvell Partnership
  19. Stifel Comments on NVIDIA-Marvell Partnership
  20. Arete Upgrades Analog Devices to Buy, $389 Price Target
  21. Goldman Sachs Initiates Coverage on Qualcomm at Neutral
  22. Bernstein SocGen Group Reiterates Outperform Rating on Oracle
  23. Morgan Stanley Lowers Meta Price Target to $775, Names New Top Pick
  24. Citi Raises TSMC Price Target to NT$2,800
  25. JPMorgan Raises BYD Price Target to RMB120
  26. Cantor Fitzgerald Reiterates Neutral on Rivian After $1B Investment
  27. GLJ Research Reiterates Sell Rating and $24.86 PT on Tesla
  28. Canaccord Lowers Tesla Price Target to $420
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.